Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation

References

1. ↵
   Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33:2866–71

   Abstract/FREE Full Text
2. ↵
   Furlan A, Higashida R, Wechler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
3. ↵
   Tong DC, Adami A, Moseley MP, et al. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol 2001;58:587–93

   CrossRefPubMed
4. ↵
   Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047–52

   Abstract/FREE Full Text
5. ↵
   Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007;24:1–10. Epub 2007 May 22.

   PubMedWeb of Science
6. ↵
   Liebeskind DS. Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am 2005;15:553–73

   CrossRefPubMedWeb of Science
7. ↵
   Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679–85

   Abstract/FREE Full Text
8. ↵
   Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke: The NINDS t-PA Stroke Study Group. Stroke 1997;28:2109–18

   Abstract/FREE Full Text
9. ↵
   Christoforidis GA, Mohammad Y, Kehagias D, et al. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789–97

   Abstract/FREE Full Text
10. ↵
    Christoforidis GA, Slivka A, Mohammad Y, et al. Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis. Stroke 2007;38:1799–804

    Abstract/FREE Full Text
11. ↵
    Higashida RT, Furlan AJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109–37

    CrossRef
12. ↵
    Khatri P, Neff J, Broderick JP, et al, for the IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;35:2400–03
13. ↵
    Arnold M, Nedeltchev K, Remonda L, et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373–76

    Abstract/FREE Full Text
14. ↵
    Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;353:1245–51
15. ↵
    Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: The ATLANTIS Study—a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–26

    CrossRefPubMedWeb of Science
16. Kidwell CS, Saver JL, Carnado J, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33:717

    Abstract/FREE Full Text
17. Del Zoppo G, Poeck K, Pessin M, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86

    CrossRefPubMedWeb of Science
18. ↵
    Larrue V, von Kummer R, del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957–60

    Abstract/FREE Full Text
19. Levy D, Brott T, Haley C, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291–97

    Abstract/FREE Full Text
20. Suarez J, Sunshine J, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094–100

    Abstract/FREE Full Text
21. Demchuk A, Morgenstern L, Krieger D, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30:34–39

    Abstract/FREE Full Text
22. ↵
    Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–10

    Abstract/FREE Full Text
23. ↵
    Gasche Y, Copin JC, Sugawara T, et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain-barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001;21:1393–400

    CrossRefPubMedWeb of Science
24. Castellanos M, Leira R, Serena J, et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003;34:40–46

    Abstract/FREE Full Text
25. ↵
    Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431–40

    Abstract/FREE Full Text
26. ↵
    Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
27. ↵
    Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain-barrier injury after forebrain ischemia in rats. Stroke 1993;24:111–16

    Abstract/FREE Full Text
28. Kawai N, Keep RF, Betz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 1997;28:149–54

    Abstract/FREE Full Text
29. ↵
    Hamann GF, del Zoppo GJ, von Kummer R. Hemorrhagic transformation of cerebral infarction: possible mechanisms. Thromb Haemost 1999;82:92–94

    PubMed